Changing sources
Early clinical growth hormone treatments were derived from human pituitary tissue. Advances in biotechnology later made it possible to manufacture recombinant human growth hormone, known as somatropin.
Today
Modern products have specific approved indications and product instructions. Their existence does not imply a general wellness or anti-aging use. A clinician decides whether a particular patient should receive treatment.
This article is for general information, not individual medical advice. Discuss indications, risks, monitoring and alternatives with a licensed provider. An evaluation does not guarantee a prescription.
← Back to all articles